Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells
about
A urokinase receptor-associated protein with specific collagen binding propertiesGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionAn old enzyme with a new function: purification and characterization of a distinct matrix-degrading metalloproteinase in rat kidney cortex and its identification as meprinTransmigration of neural stem cells across the blood brain barrier induced by glioma cellsMatrix metalloproteinase-2 and -9 involvement in canine tumorsHomophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxideGeneration and degradation of human endostatin proteins by various proteinasesDevelopmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis.Hemostasis and alterations of the central nervous systemHuman immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB.A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.Apoptosis in amphibian organs during metamorphosisInteraction between pathogenic bacteria and intrauterine leukocytes triggers alternative molecular signaling cascades leading to labor in womenMMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9.Matrix Metalloproteinase-3 (MMP-3) Is an Endogenous Activator of the MMP-9 Secreted by Placental Leukocytes: Implication in Human Labor.A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation.Pharmacological inhibition of gelatinase B induction and tumor cell invasion.Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardiumInostamycin prevents malignant phenotype of cancer: inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma.Choriodecidual cells from term human pregnancies show distinctive functional properties related to the induction of labor.Extracellular matrix roles during cardiac repair.Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity.Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4.Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen.Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells.MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.Degradation of interleukin 1beta by matrix metalloproteinases.Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.Monoclonal antibodies to human MMP-9.Hydrocortisone induces the synthesis of alpha 2-macroglobulin by rat mammary myoepithelial cells.Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
P2860
Q22011054-71018762-92F5-4B46-9EB3-A707E57340A3Q24568374-F7BEE9F3-AF47-4A17-86A8-A926EAC7D2C0Q24673211-8B745EA6-F092-4A43-A940-74A804051C4FQ27329613-84131AE7-5862-4D0B-BE93-7AACFFD776D4Q28181916-2345238F-CAB1-40F6-811D-DC95FAC3E472Q28215016-EB9AEE5D-D5A5-452B-BC06-EF346523F88EQ28539921-D2826DF2-842E-4059-B7FB-69AC404D19E9Q28610281-E263EFC2-0648-439E-A88A-AB59CF0CB646Q33305124-E60AC32E-315A-4AEF-8E19-3D05A11357D6Q33842161-45939063-6A61-4071-B248-EA7AE6067196Q33882080-27D149B9-86D9-4D93-ABFC-E897AE2C9917Q34075901-6FD939E6-BCE2-417C-BA14-08146677D025Q34104517-260A7800-676E-4881-9B85-0A65E6B768F9Q34290879-3756AB1A-6D41-4F58-A2FB-6A2C4627F314Q34405713-D90CAF30-9AEA-48CF-8016-4251D9EE11AAQ35880405-87FCAC21-42C2-493E-9AF6-38BC84306F54Q36201708-D2566958-E42F-4BF1-A248-EB8149CD5E0DQ36292014-989C7A1A-5FCB-4E87-9456-62BE670E01DFQ36390133-DCA50B77-C820-4EF1-93B6-16F62F32F5EEQ36732007-E505476A-7352-4B11-85F1-D09F41FD8348Q36813971-EC97CAFC-C2A3-4DBC-9192-A79BCF8B131CQ36959251-31D2E32F-542B-49D3-B263-EE7660B1BEABQ37352123-20296DBE-3AE4-4766-A02F-658C573E6046Q37356852-4FEB6310-9CAC-424C-9738-FB14BC8A2023Q37673218-EAF978CD-C672-4890-B899-1754B38DBF86Q37724220-FE08A682-D7A9-45F2-AEE8-4B7EF2452CECQ37776560-AD7EC0D8-BAD4-4EA3-A400-A8CE4F4FD4DCQ38316092-919B38DD-9283-4452-B483-6201B7A728AEQ39812597-4EC5A42A-2DAE-4066-9DA4-002B1CDE6002Q39866899-AA7A5843-FBB0-4642-AE9A-11759ADBF8BBQ39990465-E8AC4045-D85B-423D-B26E-07E2EF98B835Q40566666-31CF47DF-E2E4-4221-8B8D-07E7BCF8192DQ40974308-0EC0338D-57E7-418F-99E9-DC834233E55CQ41176062-45F1D4B9-E5E5-4D42-B8CF-CD6B019B6159Q41190792-B6026968-7E2A-4729-A772-A42724BABED4Q41377495-497E10BC-0078-4B44-8390-BF8ABFDA4FFAQ41442903-D3C2091F-0FA9-46E5-AFA5-F578A970CE3EQ41547659-2E9E3660-42D3-418C-BF22-8BA1B52682B5Q41561677-D823DF66-91E4-4C74-BBDC-DFE3F47FFC60Q41677243-C72C8F38-C9F7-4822-99B0-9380A74AE677
P2860
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Purification and characterizat ...... and HT1080 fibrosarcoma cells
@en
type
label
Purification and characterizat ...... and HT1080 fibrosarcoma cells
@en
prefLabel
Purification and characterizat ...... and HT1080 fibrosarcoma cells
@en
P2093
P2860
P356
P1433
P1476
Purification and characterizat ...... and HT1080 fibrosarcoma cells
@en
P2093
P2860
P304
P356
10.1042/BJ2850603
P407
P478
285 ( Pt 2)
P577
1992-07-01T00:00:00Z